Jonathan Smith

Alphavax Human Vaccines, Inc.

$21,963,803

Attributed

$24,003,624

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY2005–16

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

Funding mix

By agency

NIH$24,003,624 · 7

By mechanism

U01$16,104,525 · 3

UC1$4,839,367 · 1

R44$2,772,518 · 2

R43$287,214 · 1

Top collaborators

Jeffery Alexander4 shared
Marc Joseph Gurwith4 shared

Most similar at Alphavax Human Vaccines, Inc.

Same institution · by research overlap

Robert Olmsted$7,887,006

Others in their field

Top investigators on “Replicon”

Charles M. Rice · Rockefeller University$17,960,348
Richard J. Kuhn · Purdue University$15,751,691
Jeffrey D Chulay · Alphavax Human Vaccines, Inc.$13,968,680
Barton F Haynes · Duke University$10,283,290
Robert E. Johnston · University Of North Carolina Chapel Hill$9,919,523
Sujan Shresta · La Jolla Institute For Immunology$9,260,067

Research focus

RepliconLaboratory MouseEnzyme Linked Immunosorbent AssayVector VaccineVirusAnimalsImmunogenicityAntigensVaccinesVectorDoseProteinsNeutralizing AntibodyCooperative StudyIn VitroBaseProductionProgramsVenezuelan Equine Encephalitis VirusGlycoproteinsImmune ResponseAntibodiesNonhuman PrimateVaccine Development